| 摘要 |
The present invention concerns the use of an anti-A3 adenosine receptor (A3AR) immunoglobulin-based molecule for the preparation of a pharmaceutical composition for the treatment of a pathological condition associated with a high level of expression of A3 adenosine receptor. Further provided by the invention is a method of treating a pathological condition associated with a high level of expression of A3 adenosine receptor in a subject, the method comprising administering to said subject an amount of the anti-A3AR immunoglobulin-based molecule, the amount being effective to treat or prevent said pathological condition. Finally, the present invention provides a pharmaceutical composition for the treatment of a pathological condition associated with a high level of expression of A3AR comprising a physiologically acceptable carrier and the anti A3AR immunoglobulin-based molecule.
|
